Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 19
163
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Gold mediated sp3αC-H functionalization of steroidal diglycoside and their anti-cancer evaluation

&
Pages 3269-3276 | Received 03 Jul 2019, Accepted 13 Nov 2019, Published online: 29 Nov 2019
 

Abstract

C(sp3)-H alkylation at α-position of methyl-keto group on D-ring of Steroidal diglycoside (SG) with (i) C=N of Schiff base imines to form amine derivatives and (ii) C=C of acrylate Michael acceptors to form Markovnikov ester products using AuCl3/NHC as pre-catalyst and Ag(I) salts as co-catalyst was described. The original form of SG (1) and its derivatives (3b-f & 5a-d) were screened for in vitro anti-cancer activity specifically on two breast cancer cell lines (i.e. MCF-7, MDA-MB-231) and deduced the structure-activity-relationship with the support of molecular docking studies. Among these compounds 3b, 3f, 5b & 5d have shown more potent anticancer activity than standard drug cisplatin with considerable IC50 values.

Graphical Abstract

Acknowledgements

One of the authors Dr. S. Kankala is thankful to CSIR, New Delhi for the award of Research Associate.

Disclosure statement

The authors have no conflicts of interest in this work.

Additional information

Funding

Council of Scientific & Industrial Research (CSIR).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.